公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2012 | THE ROLES OF GROWTH ARREST DNA DAMAGE-INDUCIBLE GENE 45 Gamma (GADD45 Gamma) EXPRESSION IN SORAFENIB-INDUCED APOPTOSIS IN HEPATOCELLULAR CARCINOMA (HCC) CELLS | Hsu, C.; Ou, D. -L.; Shiau, C. -W.; Fan, H. -H.; Liao, S. -C.; Lin, Y. -Y.; Hsu, C. -H.; Cheng, A. -L.; 鄭安理; 徐志宏 | Ann. Oncol. | | | |
2011 | Signal transducer and activator of transcription 3 is a major kinase- independent target of sorafenib in hepatocellular carcinoma=STAT3為 Sorafenib於肝癌的主要標的 | TAI, WEI-TIEN; CHENG, ANN-LII; SHIAU, CHUNG-WAI; HUANG, HSIANG-PO; HUANG, JUI-WEN; CHEN, PEI-JER; CHEN, KUEN-FENG; 鄭安理; 陳培哲 | Journal of Hepatology | | | |
2008 | Sorafenib Is Effective in Patients from the Asia-Pacific Region with Hepatocellular Carcinoma (Hcc) Subgroup Analysis of Effect of Macroscopic Vascular Invasion, Extrahepatic Spread, and Ecog Performance Status on Outcome | TSAO, CHAO-JUNG; CHENG, ANN-LII; 鄭安理 | HEPATOLOGY | | | |
1986 | Spinal Cord Involvement in Systemic Lupus Erythematous:A Case Report of Two Cases and Literature Review | 鄭安理; Lin, K, T.; Chen, Ching-Yu; Lee, T. K. | Journal of Rheumatology Republic of China | | | |
2003 | Steroid-Free Chemotherapy Decreases Risk of Hepatitis B Virus (Hbv) Reactivation in Hbv-Carriers with Lymphoma | CHENG, ANN-LII; SU, IH-JEN; TIEN, HWEI- FANG; 鄭安理 | HEPATOLOGY | | | |
2003 | Steroid-Tree Chemotherapy Decreases Hepatitis B Virus (Hbv) Reactivation in Hbv-Carrier Lymphoma Patients | CHENG, ANN-LII; HSIUNG, CHAO A.; SU, IH-JEN; CHEN, PEI-JER; CHANG, MING-CHIH; TSAO, CHAO-JUNG; KAO, WOEI-YAU; UEN, WU-CHING; HSU, CHIH-HUNG; TIEN, HWEI-FANG; CHAO, TSU -YI; CHEN, LI-TZONG; WHANG-PENG, JACQUELINE; 鄭安理; 陳培哲 | HEPATOLOGY | | | |
2007 | Sulfasalazine Suppresses Drug Resistance and Invasiveness of Lung Adenocarcinorna Cells Expressing Axl | LAY, JONG-DING; HUANG, JHY-SHRIAN; LAI, GI-MING; CHENG, ANN-LII; SU, IH-JEN; CHUANG, SHUANG-EN; 鄭安理 | CANCER RESEARCH | | | |
2013 | Survival of patients receiving radiofrequency ablation or ethanol injection for early-stage hepatocellular carcinoma. | Lin, Zhong-Zhe; Shau, Wen-Yi; Shao, Yu Yun; 鄭安理 | J. Clin. Oncol. | | | |
1993 | Test Dose Guided Rapid IV Suramine Infusions with Weekly IV Maintenance Doses | Arzoomanian, R.; Rago, R.; Cheng, Ann-Lii; Tombes, M. B.; Alberti, D.; Tusch, K.; Mutch, R.; 鄭安理 | Proceedings:Annual Meeting of the American Society of Clinical Oncology | | | |
2014 | The impact of diabetes mellitus on early cervical cancer in Asia: A population-based cohort study | Kuo, Hung-Yang; Lin, Zhong-Zhe; Kuo, Raymond Nienchen; Shau, Wen-Yi; Lai, Chiu-Lin; Yang, Yen-Yun; Shao, Yu Yun; Hsu, Chiun; Chang, Wen-Fang; Chang, Ann-Lii; Yang, James Chih-Hsin; Lai, Mei-Shu; 鄭安理 | J. Clin. Oncol. | | | |
2015 | Therapeutic effect of sorafenib is attenuated by tumor-infiltrating Ly6G+myeloid-derived suppressor cells (MDSCs) and is restored by anti-interleukin-6 (IL-6) antibody treatment in an orthotopic mouse liver cancer model | Chang, Chun-Jung; Yang, Yao-Hsu; Chiu, Chiao-Juno; Chiang, Bor-Luen; Lee, Xiao-yi; Hsu, Chih-Hung; Cheng, Ann-Lii; 鄭安理 | Cancer Res. | 0 | 0 | |
1994 | Use of Retinoic Acids in the Treatment of Peripheral T-Cell Lymphoma:a Pilot Study | 鄭安理 | Journal of Clinical Oncology | | | |
2013 | Vascular endothelial growth factor expression in hepatitis C virus (HCV)-related advanced hepatocellular carcinoma (HCC) compared with hepatitis B virus (HBV)-related advanced HCC | Shao, Yu Yun; Hsieh, Min-Shu; Huang, Chung-Yi; Chang, Yung-Ling; Hsu, Chih-Hung; Cheng, Ann-Lii; 鄭安理 | J. Clin. Oncol. | | | |
1994 | Weekly 24-Hour Infusion with High-Dose 5 Fluorouracil Plus Leucovorin (HDFL) in Metastatic Colorectal Carcinoma | Cheng, Ann-Lii; Lin, M. T.; Wang, C. Y.; Wang, C. H.; Chen, Yee-Chun; Yeh, K. H.; 鄭安理 | Annual Meeting of Chinese Oncology Society | | | |
2013 | WNT/beta-catenin signaling inhibitors improve the anti-proliferative effect of sorafenib against hepatocellular carcinoma (HCC) cells. | Lin, Hsiao-Hui; Feng, Wen-Chi; Lu, Li-Chun; Shao, Yu-Yun; Cheng, Ann-Lii; Hsu, Chih-Hung; 鄭安理 | Cancer Res. | | | |
1987 | 以異體骨髓移植治療白血病之成果初報 | 陳耀昌; 王秋華; 林東燦; 雷德; 鄭安理; 劉滄梧; 蔡偉; 田蕙芬(Tien, Hwei-Fang); 劉美瑾; 褚文銘; 李麗娜; 蘇益仁(Su, Ih-Jen); 謝榮峰(Hsieh, Rong-Phong); 沈銘鏡(Shen, Ming-Ching); 劉禎輝(Hsieh | o-Sin | | | |
2008 | 內科系醫學(二)學門規劃研究推動計畫 | 鄭安理 | | | | |
2007 | 內科系醫學(二)學門規劃研究推動計畫 | 鄭安理 | | | | |
2005 | 原發性中樞神經系統淋巴瘤之研究 | 林璟宏; Lin, Ching-Hung | | | | |
1998 | 可溶性FAS接受體(SFAS)與胃癌之「嚴重度」與「化學治療反應性」相關性之研究 | 鄭安理 | | | | |